Tyrosine hydroxylase inhibitors for treatment of aortic aneurysm
Two Spanish research institutions have found the potential of tyrosine hydroxylase inhibitors for prevention and treatment of aortic aneurysm, thus reducing aortic damage. Companies interested in patent licensing and/or in a research collaboration for the development of its application are sought.